Cozart granted UK patent on saliva collection

26 March 2006

UK-based medical diagnostics firm Cozart has been granted a UK patent number GB2391813, entitled Oral fluid collection and transfer device.

According to the firm, the new patent covers aspects of a novel device for the collection of a saliva sample and its transfer either back to a laboratory for testing or direct use on-site with, for example, point-of-care drugs of abuse tests or infectious disease tests.

The technology covered under the patent is part of an in-house development program at Cozart, which is designed to enhance and expand its oral fluid collection and testing product portfolio for commercial sale and distribution in the future.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight